News

Applied Clinical Trials Online24m

Response’s Investigational Small Molecule Inhibitor Shows Promising Post-GLP-1 Weight Management, Cardiometabolic Benefits

Results from a Phase II trial (NCT06640972) showed that patients treated with RDX-002 experienced significant reductions in ...
Applied Clinical Trials Online1h

Balancing Speed and Rigor in Accelerated Trial Pathways

In this video interview, Meri Beckwith, Co-CEO of Lindus Health, explains why sponsors pursuing breakthrough or priority ...
Applied Clinical Trials Online2h

Why Sponsors Should Consider a Hybrid Approach for Clinical Trial Payments

Bringing some payment activities in-house while outsourcing others can help sponsors optimize clinical trial efficiency, ...
Applied Clinical Trials Online22h

Phase III VAYHIT2 Trial Demonstrates Ianalumab Plus Eltrombopag Extends Disease Control in Primary Immune Thrombocytopenia

In the Phase III VAYHIT2 trial, ianalumab combined with eltrombopag significantly prolonged time to treatment failure and ...
Applied Clinical Trials Online23h

Phase III EV-303/KEYNOTE-905 Shows Padcev Plus Keytruda Improves Event-Free and Overall Survival in Muscle-Invasive Bladder Cancer

In this Phase III trial, the Padcev-Keytruda combination used as both neoadjuvant and adjuvant therapy significantly improved event-free and overall survival, as well as pathologic complete response, ...